




Searching News Database: Tercica
HSMN NewsFeed - 25 Feb 2009
Proteolix Announces the Appointment of John Scarlett, M.D., President and CEO
Proteolix Announces the Appointment of John Scarlett, M.D., President and CEO
HSMN NewsFeed - 12 Jan 2009
Hana Biosciences Appoints Thomas J. Tarlow as Vice President, Regulatory Affairs and Quality
Hana Biosciences Appoints Thomas J. Tarlow as Vice President, Regulatory Affairs and Quality
HSMN NewsFeed - 14 Jul 2008
Cortria Corporation Announces Appointment of Daniel Grau as CEO & Vice-Chairman and Richard King as Director
Cortria Corporation Announces Appointment of Daniel Grau as CEO & Vice-Chairman and Richard King as Director
HSMN NewsFeed - 4 Oct 2007
Hyperion Therapeutics, Inc. Announces Senior Management Team and $15M Financing Event
Hyperion Therapeutics, Inc. Announces Senior Management Team and $15M Financing Event
HSMN NewsFeed - 31 Aug 2007
Ipsen: Somatuline(R) Depot Receives Marketing Approval in the United States for the Treatment of Acromegaly
Ipsen: Somatuline(R) Depot Receives Marketing Approval in the United States for the Treatment of Acromegaly
HSMN NewsFeed - 30 Aug 2007
Somatuline(R) Depot Receives FDA Marketing Approval for the Treatment of Acromegaly
Somatuline(R) Depot Receives FDA Marketing Approval for the Treatment of Acromegaly
HSMN NewsFeed - 25 May 2007
Ipsen: Increlex(R) Receives CHMP Positive Opinion for the Treatment of Severe Primary IGF-1 Deficiency
Ipsen: Increlex(R) Receives CHMP Positive Opinion for the Treatment of Severe Primary IGF-1 Deficiency
HSMN NewsFeed - 28 Feb 2007
Tercica Announces the Appointment of Richard A. King as Chief Operating Officer
Tercica Announces the Appointment of Richard A. King as Chief Operating Officer
HSMN NewsFeed - 16 Jan 2007
Tercica Reports Somatuline(R) Autogel(R) NDA for Acromegaly Accepted for Filing by FDA
Tercica Reports Somatuline(R) Autogel(R) NDA for Acromegaly Accepted for Filing by FDA
HSMN NewsFeed - 15 Jan 2007
FDA Accepts for Filing a New Drug Application (NDA) for Somatuline(R) Autogel(R)
FDA Accepts for Filing a New Drug Application (NDA) for Somatuline(R) Autogel(R)
HSMN NewsFeed - 10 Jan 2007
Italian Ministry of Health Requests IPLEX(TM) for Treatment of ALS (Lou Gehrig's Disease)
Italian Ministry of Health Requests IPLEX(TM) for Treatment of ALS (Lou Gehrig's Disease)
HSMN NewsFeed - 6 Dec 2006
Jury Finds Insmed Infringed Patents Owned By Genentech And Exclusively Licensed to Tercica
Jury Finds Insmed Infringed Patents Owned By Genentech And Exclusively Licensed to Tercica
HSMN NewsFeed - 2 Nov 2006
Tercica Reports Somatuline(R) Autogel(R) NDA for Acromegaly Submitted to FDA
Tercica Reports Somatuline(R) Autogel(R) NDA for Acromegaly Submitted to FDA
HSMN NewsFeed - 31 Oct 2006
Jody LoMenzo Named Director, Investor Relations and Corporate Communications
Jody LoMenzo Named Director, Investor Relations and Corporate Communications
HSMN NewsFeed - 16 Oct 2006
Ipsen and Tercica Complete Worldwide Strategic Collaboration Agreement in Endocrinology
Ipsen and Tercica Complete Worldwide Strategic Collaboration Agreement in Endocrinology
Additional items found! 24

Members Archive contains
24 additional stories matching:
Tercica
(Password required)
Tercica
(Password required)